chr9-32984805-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_001195248.2(APTX):c.596G>A(p.Arg199His) variant causes a missense change. The variant allele was found at a frequency of 0.0011 in 1,614,150 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0055 ( 10 hom., cov: 32)
Exomes 𝑓: 0.00064 ( 9 hom. )
Consequence
APTX
NM_001195248.2 missense
NM_001195248.2 missense
Scores
1
10
6
Clinical Significance
Conservation
PhyloP100: 6.16
Genes affected
APTX (HGNC:15984): (aprataxin) This gene encodes a member of the histidine triad (HIT) superfamily. The encoded protein may play a role in single-stranded DNA repair through its nucleotide-binding activity and its diadenosine polyphosphate hydrolase activity. Mutations in this gene have been associated with ataxia-ocular apraxia. Alternatively spliced transcript variants have been identified for this gene.[provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
PM1
In a domain HIT (size 105) in uniprot entity APTX_HUMAN there are 24 pathogenic changes around while only 2 benign (92%) in NM_001195248.2
BP4
Computational evidence support a benign effect (MetaRNN=0.012209952).
BP6
Variant 9-32984805-C-T is Benign according to our data. Variant chr9-32984805-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 214120.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-32984805-C-T is described in Lovd as [Pathogenic]. Variant chr9-32984805-C-T is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00547 (833/152274) while in subpopulation AFR AF= 0.0188 (780/41546). AF 95% confidence interval is 0.0177. There are 10 homozygotes in gnomad4. There are 389 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APTX | NM_001195248.2 | c.596G>A | p.Arg199His | missense_variant | 6/8 | ENST00000379817.7 | NP_001182177.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APTX | ENST00000379817.7 | c.596G>A | p.Arg199His | missense_variant | 6/8 | 1 | NM_001195248.2 | ENSP00000369145 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00547 AC: 832AN: 152156Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
832
AN:
152156
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00163 AC: 410AN: 251468Hom.: 8 AF XY: 0.00136 AC XY: 185AN XY: 135910
GnomAD3 exomes
AF:
AC:
410
AN:
251468
Hom.:
AF XY:
AC XY:
185
AN XY:
135910
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000642 AC: 939AN: 1461876Hom.: 9 Cov.: 32 AF XY: 0.000626 AC XY: 455AN XY: 727242
GnomAD4 exome
AF:
AC:
939
AN:
1461876
Hom.:
Cov.:
32
AF XY:
AC XY:
455
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00547 AC: 833AN: 152274Hom.: 10 Cov.: 32 AF XY: 0.00522 AC XY: 389AN XY: 74454
GnomAD4 genome
AF:
AC:
833
AN:
152274
Hom.:
Cov.:
32
AF XY:
AC XY:
389
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
80
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
251
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Feb 22, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | APTX: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 18, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 01, 2017 | - - |
APTX-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 22, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;.;.;.;.;D;.;.;.;.;D;D;D
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;.;D;.;.;D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;.;.;.;M;.;.;.;.;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;.;D;D;D;D;D;D;.;D;D;D
REVEL
Uncertain
Sift
Benign
T;.;.;D;D;D;D;D;D;.;D;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;.;.;.
Polyphen
0.77, 0.86, 0.63, 0.99
.;.;P;P;.;P;.;.;.;.;.;D;.
Vest4
MVP
MPC
0.28
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at